C
Christina Wang
Researcher at Los Angeles Biomedical Research Institute
Publications - 450
Citations - 30621
Christina Wang is an academic researcher from Los Angeles Biomedical Research Institute. The author has contributed to research in topics: Testosterone (patch) & Sperm. The author has an hindex of 88, co-authored 422 publications receiving 27941 citations. Previous affiliations of Christina Wang include Queen Mary University of London & Cedars-Sinai Medical Center.
Papers
More filters
Journal ArticleDOI
World Health Organization reference values for human semen characteristics
Trevor G. Cooper,Elizabeth A. Noonan,Sigrid von Eckardstein,Jacques Auger,H.W. Gordon Baker,Hermann M. Behre,Trine B. Haugen,Thinus F. Kruger,Christina Wang,Michael T. Mbizvo,Kirsten M. Vogelsong +10 more
TL;DR: Semen quality of the reference population was superior to that of the men from the general population and normozoospermic men, and provide an appropriate tool in conjunction with clinical data to evaluate a patient's semen quality and prospects for fertility.
Journal ArticleDOI
Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men
Christina Wang,Ronald S. Swerdloff,Ali Iranmanesh,Adrian S. Dobs,Peter J. Snyder,Glenn R. Cunningham,Alvin M. Matsumoto,Thomas Weber,Nancy Berman +8 more
TL;DR: It is concluded that T gel replacement improved sexual function and mood, increased lean mass and muscle strength (principally in the legs), and decreased fat mass in hypogonadal men with less skin irritation and discontinuation compared with the recommended dose of the permeation-enhanced T patch.
Journal ArticleDOI
Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.
Christina Wang,Glenn R. Cunningham,Adrian S. Dobs,Ali Iranmanesh,Alvin M. Matsumoto,Peter J. Snyder,Thomas Weber,Nancy Berman,Laura Hull,Ronald S. Swerdloff +9 more
TL;DR: It is concluded that continued application of AndroGel resulted in beneficial effects similar to those with injectables and other transdermal preparations and monitoring for prostatic disease and assessment for erythrocytosis are strongly advised to reduce the risk of adverse events with T treatment of hypogonadal men.
Journal ArticleDOI
Investigation, Treatment and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations
Christina Wang,Eberhard Nieschlag,Ronald S. Swerdloff,Hermann M. Behre,Wayne J.G. Hellstrom,Louis Gooren,Jean-Marc Kaufman,Jean-Jacques Legros,Bruno Lunenfeld,Alvaro Morales,John E. Morley,Claude Schulman,Ian M. Thompson,Wolfgang Weidner,Frederick C. W. Wu +14 more
TL;DR: The new ISA, ISSAM, EAU, EAA and ASA recommendations on the investigation, treatment and monitoring of late-onset hypogonadism in males provide updated evidence-based information for clinicians who diagnose and treat patients with adult onset, age related testosterone deficiency.
Journal ArticleDOI
Effects of Testosterone Treatment in Older Men
Peter J. Snyder,Shalender Bhasin,Glenn R. Cunningham,Alvin M. Matsumoto,Alisa J. Stephens-Shields,J. A. Cauley,Thomas M. Gill,Elizabeth Barrett-Connor,Ronald S. Swerdloff,Ronald S. Swerdloff,Christina Wang,Christina Wang,Kristine E. Ensrud,Cora E. Lewis,John T. Farrar,David Cella,Raymond C. Rosen,Marco Pahor,Jill P. Crandall,Mark E. Molitch,Denise Cifelli,Darlene Dougar,Laura Fluharty,Susan M. Resnick,Thomas W. Storer,Stephen D. Anton,Shehzad Basaria,Susan J. Diem,X. Hou,Emile R. Mohler,J. K. Parsons,Nanette K. Wenger,Bret Zeldow,J. R. Landis,Susan S. Ellenberg +34 more
TL;DR: In symptomatic men 65 years of age or older, raising testosterone concentrations for 1 year from moderately low to the mid-normal range for men 19 to 40 years ofAge had a moderate benefit with respect to sexual function and some benefit withrespect to mood and depressive symptoms but no benefit with Respect to vitality or walking distance.